Omega Fund Vi, L.P. is of Theseus Pharmaceuticals, Inc.. Currently has a direct ownership of 711,479 shares of THRX, which is worth approximately $0. The most recent transaction as insider was on Oct 12, 2021, when has been sold 187,500 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $3,000,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 711K
0% 3M change
0% 12M change
Total Value Held $0

Omega Fund VI, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 12 2021
BUY
Open market or private purchase
$3,000,000 $16.0 p/Share
187,500 Added 20.86%
711,479 Common Stock
Oct 12 2021
BUY
Conversion of derivative security
-
523,979 Added 50.0%
523,979 Common Stock

Also insider at

IMGO
Imago BioSciences, Inc. Healthcare
SPRB
SPRUCE BIOSCIENCES, INC. Healthcare
LXEO
Lexeo Therapeutics, Inc.
OFV

Omega Fund Vi, L.P.

Boston, MA

Track Institutional and Insider Activities on THRX

Follow Theseus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells THRX shares.

Notify only if

Insider Trading

Get notified when an Theseus Pharmaceuticals, Inc. insider buys or sells THRX shares.

Notify only if

News

Receive news related to Theseus Pharmaceuticals, Inc.

Track Activities on THRX